Skip to main content
SpringerLink
Log in

5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

In this study we have examined the acute effects of systemic administration of the selective serotonin reuptake inhibitor (SSRI), citalopram, in combination with either of the two selective 5-HT1A receptor antagonists, (S)-5-fluoro-8-hydroxy-2-(dipropylamino)-tetralin [(S)-UH-301] or (+)-N-tertbutyl 3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylpropionamide dihydrochloride [(+)-WAY100135], on the activity of single 5-HT neurons in the dorsal raphe nucleus (DRN) of anesthetized rats using extracellular recording techniques. Acute administration of citalopram (0.3 mg/kg i.v.) significantly decreased the firing rate of DRN-5-HT cells most likely as a result of indirect stimulation of inhibitory somatodendritic 5-HT1A autoreceptors located on 5-HT cells in the DRN. This effect of citalopram was completely reversed by (S)-UH-301 (0.5 mg/kg i.v.) and partly by (+)WAY100135 (0.5 mg/kg i.v.). Furthermore, the inhibitory effect of citalopram on the activity of 5-HT neurons was significantly attenuated by pretreatment with (S)-UH-301 (0.25 mg/kg i.v.) or (+)-WAY100135 (0.25 mg/kg i.v.).

We have also studied the effects of (S)-UH-301 (0.03–0.50 mg/kg i.v.) on the firing rate of single DRN5-HT cells in rats chronically treated with citalopram (20 mg/kg/day i.p. × 14 days). Administration of (S)UH-301 significantly and dose-dependently increased the activity of 5-HT cells in citalopram-treated rats, but did not affect these neurons in saline-treated (1 m1/kg/day i.p. × 14 days), control rats. Our results thus suggest that 5-HT1A receptor antagonists can augment both the acute and chronic effects of citalopram on central serotonergic neurotransmission. Since the antidepressant effect of SSRIs is critically linked to the availability of 5-HT, these findings support the notion that 5-HT1A receptor antagonists may not only shorten the latency of onset of SSRIs in the treatment of depression, but also increase their efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adell A, Artigas F (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn-Schmiedeberg's Arch Pharmacol 343:237–244

    Google Scholar 

  • Aghajanian GK (1978) Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 278:186–188

    Google Scholar 

  • Aghajanian GK, Wang RY, Barban J (1978) Serotonergic and non-serotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res 153:169–175

    Google Scholar 

  • Arborelius L, Chergui K, Murase S, Nomikos GG, Backlund Höök B, Chouvet G, Hacksell U and Svensson TH (1993) The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn-Schmiedeberg's Arch Pharmacol 347:353–362

    Google Scholar 

  • Arborelius L, Backlund Höök B, Hacksell U, Svensson TH (1994) The 5-HT1A receptor antagonist (S)-UH-301 blocks the (R)-8OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing. J Neural Transm (GenSect) 96:179–186

    Google Scholar 

  • Arnt J, Fredricson Overö K, Hyttel J, Olsen R (1984) Changes in rat dopamine- and serotonin function in vivo after prolonged administration of a specific 5-HT uptake inhibitor, citalopram. Psychopharmacology 84:457–465

    Google Scholar 

  • Artigas F (1993) 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol Sci 14:262

    Google Scholar 

  • Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reup-take inhibitors. Arch Gen Psychiatry 51:248–251

    Google Scholar 

  • Baraban JM, Aghajanian GK (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355–363

    Google Scholar 

  • Beasley CM, Masica DN, Potvin JH (1992) Fluoxetine: a review of receptor and functional effects and their clinical implications. Psychopharmacology 107:1–10

    Google Scholar 

  • Bech PA (1990) A meta-analysis of the antidepressant properties of serotonin reuptake inhibitors. Int Rev of Psychiatry 2:207–211

    Google Scholar 

  • Bel N, Artigas F (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 229:101–103

    Google Scholar 

  • Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243–245

    Google Scholar 

  • Björk L, Cornfield LJ, Nelson DL, Hillver S-E, Andén N-E, Lewander T, Hacksell U (1991) Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-2-(dipropylamino)tetralin: Inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects. J Pharmacol Exp Ther 258:58–65

    Google Scholar 

  • Blier P, de Montigny C (1983) Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 3:1270–1278

    Google Scholar 

  • Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220–226

    Google Scholar 

  • Blier P, de Montigny C, Tardif D (1984) Effects of the two anti-depressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat. Psychopharmacology 84:242–249

    Google Scholar 

  • Blier P, Steinberg S, Chaput Y, de Montigny C (1988) Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus, Can J Physiol Pharmacol 67:98–105

    Google Scholar 

  • Chaput Y, de Montigny C, Blier P (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 33:342–348

    Google Scholar 

  • Chaput Y, de Montigny C, Blier P (1991) Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. Neuropsychopharmacology 5:219–229

    Google Scholar 

  • Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry 47:411–418

    Google Scholar 

  • Edwards JG (1992) Selective serotonin reuptake inhibitors [editorial]. Br Med J 304:1644–1646

    Google Scholar 

  • Ferré S, Artigas F (1993) Dopamine D2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J Neurochem 61:772–775

    Google Scholar 

  • Ferré S, Cortés R, Artigas F (1994) Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. J Neurosci 14:4839–4846

    Google Scholar 

  • Fletcher A, Bill DJ, Bill SJ, Cliffe IA, Dover GM, Forster EA, Haskins JT, Jones D, Mansell HL, Reilly Y (1993) WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. Eur J Pharmacol 237:283–291

    Google Scholar 

  • Fredricson Overö K (1982) Kinetics of citalopram in test animals; drug exposure in saftey studies. Prog Neuro-Psychopharmacol Biol Psychiatry 6:297–309

    Google Scholar 

  • Gallager DW, Aghajanian GK (1975) Effects of chloripramine and lysergic acid diethylamide on efflux of precursor-formed 3H-serotonin: correlations with serotonergic impulse flow. J Pharmacol Exp Ther 193:785–795

    Google Scholar 

  • Gallager DW, Aghajanian GK (1976) Effect of antipsychotic drugs on the firing of dorsal raphe cells. 1. Role of adrenergic system. Eur J Pharmacol 39:341–355

    Google Scholar 

  • Hillver S-E, Björk L, Li Y-L, Svensson B, Ross S, Andén N-E, Hacksell U (1990) (S)-5-fluoro-8-hydroxy-2-(dipropylamino)-tetralin: A putative 5-HT1A-receptor antagonist. J Med Chem 33:1541–1544

    Google Scholar 

  • Hjorth S (1993) Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J Neurochem 60:776–779

    Google Scholar 

  • Hjorth S, Auerbach SB (1994) Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur J Pharmacol 260:251–255

    Google Scholar 

  • Hyttel J (1982) Citalopram — pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiatry 6:277–295

    Google Scholar 

  • Hyttel J, Fredricson Overö K, Arnt J (1984) chemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 83:20–27

    Google Scholar 

  • Invernizzi R, Belli S, Samanin R (1991) An increase of extracellular serotonin in the dorsal raphe masks the effect of sertraline in the frontal cortex. In: Rollema H, Westerink BHC, Drijfhout WJ (eds) Monitoring molecules in neuroscience. University Centre for Pharmacy, pp 253–255

  • Invernizzi R, Belli S, Samanin R (1992) Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res 584:322–324

    Google Scholar 

  • Invernizzi R, Bramante M, Samanin R (1994) Chronic treatment with citalopram facilitates the effect of a challange dose on cortical serotonin output: role of presynaptic 5-HT1A receptors. Eur J Pharmacol 260:243–246

    Google Scholar 

  • Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H, Hamon M (1994) Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a the novel antidepressant, cericlamine. J Pharmacol Exp Ther 268:1432–1443

    Google Scholar 

  • Kreiss DS, Lucki I (1993) Repeated administration of the antidepressant fluoxetine, but not desipramine or mianserin, produces desesitization of 5-HT1A autoreceptors. Soc Neurosci Abstr 19:1867

    Google Scholar 

  • Lanfumey L, Haj-Dahmane S, Hamon M (1993) Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY100135 and SDZ216–525. Eur J Pharmacol 249:25–35

    Google Scholar 

  • Lejeune F, Rivet J-M, Gobert A, Canton H, Millan M (1993) WAY100,135 and (−)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo. Eur J Pharmacol 240:307–310

    Google Scholar 

  • Lesch K-P, Poten B, Söhnle K, Schulte HM (1990) Pharmacology of the hypothermic response to 5-HT1A receptor activation in humans. Eur J Clin Pharmacol 39:17–19

    Google Scholar 

  • Maj J (1986) Repeated treatment with antidepressant drugs: responses mediated by brain dopamine receptors. In: Hippius H, Klerman GL, Matussek N (eds) New results in depression research. Springer, Berlin Heidelberg New York Tokyo, pp 90–98

    Google Scholar 

  • Martin-Iverson M, Leclere J-F, Fibiger HC (1983) Cholinergicdopaminergic interactions and the mechanism of action of anti-depressants. Eur J Pharmacol 94:193–201

    Google Scholar 

  • Nomikos GG, Arborelius L, Svensson TH (1992) The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus. Eur J Pharmacol 216:373–378

    Google Scholar 

  • Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Sydney

    Google Scholar 

  • Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88–90

    Google Scholar 

  • Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ (1990) Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci 10:2308–2317

    Google Scholar 

  • Rigdon GC, Wang CM (1991) Serotonin uptake blockers inhibit the firing of presumed serotonergic dorsal raphe neurons in vitro. Drug Dev Res 22:135–140

    Google Scholar 

  • Routledge C, Gurling J, Wright IK, Dourish CT (1993) Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study. Eur J Pharmacol 239:195–202

    Google Scholar 

  • Rutter JJ, Gundlah C, Auerbach SB (1994) Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 171:183–186

    Google Scholar 

  • Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M (1990). Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotonergic neurons in midbrain raphe nuclei. Eur J Neurosci 2:1144–1154

    Google Scholar 

  • Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotonergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonist. Synapse 1:3–9

    Google Scholar 

  • Sprouse JS, Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27:707–715

    Article  CAS  PubMed  Google Scholar 

  • Spyraki C, Fibiger HC (1981) Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 74:195–206

    Google Scholar 

  • Svensson TH (1978) Attenuated feed-back inhibition of brain serotonin synthesis following chronic administration of imipramine. Naunyn-Schmiedeberg's Arch Pharmacol 302:115–118

    Google Scholar 

  • Svensson TH, Bunny BS, Aghajanian GK (1975) Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res 92:291–306

    Google Scholar 

  • Szabo B, Karsch V, Starke K (1992) Effects of inhibitors of neuronal uptake of 5-HT on sympathetic cardiovascular regulation. J Cardiovasc Pharmacol 20:99–107

    Google Scholar 

  • Vandermaelen CP, Aghajanian GK (1983) Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res 289:109–119

    Google Scholar 

  • Yen TT, Wong DT, Bemis KG (1987) Reduction of food consumption and body weight of normal and obese mice by chronic treatment with fluoxetine: a serotonin reuptake inhibitor. Drug Dev Res 10:37–45

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology and Pharmacology, Division of Pharmacology, Karolinska Institutet, S-171 77, Stockholm, Sweden

    Lotta Arborelius, George G. Nomikos, Pernilla Grillner, Peter Hertel & Torgny H. Svensson

  2. Department of Organic Pharmaceutical Chemistry, P.O. Box 574, Uppsala University, S-751 23, Uppsala, Sweden

    Berit Backlund Höök & Uli Hacksell

Authors
  1. Lotta Arborelius
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George G. Nomikos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pernilla Grillner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Hertel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Berit Backlund Höök
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Uli Hacksell
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Torgny H. Svensson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arborelius, L., Nomikos, G.G., Grillner, P. et al. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Naunyn-Schmiedeberg's Arch Pharmacol 352, 157–165 (1995). https://doi.org/10.1007/BF00176769

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00176769

Key words

Search

Navigation